Table 2.
Selected miRNAs and proteins associated with substance addiction, withdrawal, and relapse that may be targeted by therapeutic EV-mediated delivery
| Molecule | Drug | Function | Reference |
|---|---|---|---|
| miRNA | |||
| miR-27a | Alcohol | M2 monocyte polarization | [20] |
| miR-124 | Alcohol | BDNF downregulation | [125] |
| miR-206 | Alcohol | BDNF downregulation | [126] |
| miR-9 | Alcohol | Ca2+ and K+ channel expression | [127] |
| miR-431 | Cocaine | Arc expression | [128] |
| miR-212 | Cocaine | CREB activation | [129, 130] |
| miR-101b | Cocaine | [128] | |
| miR-132 | Cocaine | CREB and BDNF-mediated synaptic plasticity | [128, 130] |
| miR-137 | Cocaine | [128] | |
| miR-190 | Fentanyl | µ opioid receptor expression | [131] |
| miR-218 | Heroin | Gabrb3, GluR2, Ube3a, Nrxn1, Gng3, and Mecp2 expression | [132] |
| Let-7d | Marijuana | CB1 receptor signaling | [122] |
| Let-7a/c/g | Morphine | µ opioid receptor expression | [107] |
| miR-27a | Morphine | Serpini1 expression | [133, 134] |
| miR-29b | Morphine | [50] | |
| miR-140-5p | Nicotine | Inhibits Dynamin-1 expression | [135] |
| miR-504 | Nicotine | Upregulates dopamine D1 receptors | [136] |
| miR-542-3p | Nicotine | Increased nicotinic acetylcholine receptors | [137] |
| Protein | |||
| GLT-1 | Alcohol | Glutamate transport | [138, 139] |
| mTORC1 | Alcohol | Protein synthesis/translation | [140] |
| LGALS3 | Cocaine (+ HIV) | Neuronal migration | [141] |
| GLUL | Cocaine (+ HIV) | Glutamate detoxification | [141] |
| HBB/HBD | Cocaine (+ HIV) | Learning and memory | [141] |
| MCP-5 | Methamphetamine | Chemokine | [142] |
| sTNFR1 | Methamphetamine | Chemokine | [142] |
| NMDAR1 | Morphine | Glutamate receptor | [143] |
| p-CREB | Morphine | Cellular transcription | [144] |
| Arc/Arg3.1 | Morphine | Synaptic plasticity/memory | [145, 146] |